The UK charity for WM & LPL – a rare type of blood cancer

Support Line: 0300 373 8500
WMUK Impact Report 2024-25

WMUK Impact Report 2024–25

April 29, 2026

How we reached, supported and empowered more people living with WM and LPL than ever before.

This report sets out what WMUK achieved in 2024–25: a 100% increase in website visits following the site relaunch, 288 individuals supported through the Support Line (up 54%), the launch of the UK’s first WM and LPL Clinical Trials Hub, and the first evidence-based advocacy strategy in the charity’s history. Alongside the numbers, you’ll find patient stories, financial transparency, and a clear picture of where the charity is headed next.

PIF TICK - Trusted Information Creator

Related Documents

WM and LPL: A Guide to Treatments
Free guide to treatments for Waldenstrom’s macroglobulinaemia (WM) and lymphoplasmacytic lymphoma (LPL), from active monitoring to chemo-immunotherapy.
WMUK Impact Report 2024–25
How we reached, supported and empowered more people living with WM and LPL than ever before.
non-IgM LPL Fact Sheet
Our guide for those diagnosed with LPL